Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Oncotarget
|
February 7, 2015
GHRH-antagonists in TNBC
Jörg B Engel
Nature Clinical Practice. Endocrinology & Metabolism
|
January 24, 2007
Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone
Jörg B Engel, Andrew V Schally
Nature Clinical Practice. Endocrinology & Metabolism
|
December 18, 2007
Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer
Andrew V Schally, Jozsef L Varga, Jörg B Engel
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
August 26, 2006
Presurgical short term treatment of uterine fibroids with different doses of cetrorelix acetate: a double-blind, placebo-controlled multicenter study
Jörg B Engel, Alain Audebert, René Frydman, et al.
Reproductive Biomedicine Online
|
January 7, 2003
Inhibin A/B in HMG or recombinant FSH ovarian stimulation with cetrorelix medication
Jörg B Engel, Ricardo E Felberbaum, Thomas Reissmann, et al.
Archives of Gynecology and Obstetrics
|
September 25, 2003
Inhibin B on the day of HCG-administration is a predictive factor for failure in assisted reproduction cycles
Jörg B Engel, Ricardo E Felberbaum, Klaus Junge, et al.
Molecular Pharmaceutics
|
August 21, 2007
Targeted therapy of breast and gynecological cancers with cytotoxic analogues of peptide hormones
Jörg B Engel, Andrew V Schally, Johannes Dietl, et al.
The Journal of Obstetrics and Gynaecology Research
|
September 16, 2011
Papillary squamotransitional cell carcinoma of the vagina
Bernhard Niederle, Stephan Rauthe, Jörg B Engel, et al.
Fertility and Sterility
|
December 25, 2010
Cervical endometriosis associated with malignant pleural mesothelioma mimicking cervical cancer--Occam's razor or the "third man"
Jörg B Engel, Stefan Heuer, Sabine Segerer, et al.
International Journal of Oncology
|
May 11, 2006
Effective therapy of experimental human malignant melanomas with a targeted cytotoxic somatostatin analogue without induction of multi-drug resistance proteins
Gunhild Keller, Andrew V Schally, Attila Nagy, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Oncotarget
|
February 7, 2015
GHRH-antagonists in TNBC
Jörg B Engel
Nature Clinical Practice. Endocrinology & Metabolism
|
January 24, 2007
Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone
Jörg B Engel, Andrew V Schally
Nature Clinical Practice. Endocrinology & Metabolism
|
December 18, 2007
Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer
Andrew V Schally, Jozsef L Varga, Jörg B Engel
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
August 26, 2006
Presurgical short term treatment of uterine fibroids with different doses of cetrorelix acetate: a double-blind, placebo-controlled multicenter study
Jörg B Engel, Alain Audebert, René Frydman, et al.
Reproductive Biomedicine Online
|
January 7, 2003
Inhibin A/B in HMG or recombinant FSH ovarian stimulation with cetrorelix medication
Jörg B Engel, Ricardo E Felberbaum, Thomas Reissmann, et al.
Archives of Gynecology and Obstetrics
|
September 25, 2003
Inhibin B on the day of HCG-administration is a predictive factor for failure in assisted reproduction cycles
Jörg B Engel, Ricardo E Felberbaum, Klaus Junge, et al.
Molecular Pharmaceutics
|
August 21, 2007
Targeted therapy of breast and gynecological cancers with cytotoxic analogues of peptide hormones
Jörg B Engel, Andrew V Schally, Johannes Dietl, et al.
The Journal of Obstetrics and Gynaecology Research
|
September 16, 2011
Papillary squamotransitional cell carcinoma of the vagina
Bernhard Niederle, Stephan Rauthe, Jörg B Engel, et al.
Fertility and Sterility
|
December 25, 2010
Cervical endometriosis associated with malignant pleural mesothelioma mimicking cervical cancer--Occam's razor or the "third man"
Jörg B Engel, Stefan Heuer, Sabine Segerer, et al.
International Journal of Oncology
|
May 11, 2006
Effective therapy of experimental human malignant melanomas with a targeted cytotoxic somatostatin analogue without induction of multi-drug resistance proteins
Gunhild Keller, Andrew V Schally, Attila Nagy, et al.
Page
of 4